The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.

Researchers investigating the role of the protein CD44 in obesity and metabolic health found that CD44-deficient mice stayed ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

The results were alarming. Among PPI users, 5.6% reported kidney-related problems, compared to just 0.7% of those taking ...

Scientists at the (UNIGE) have developed a tool that uses light to precisely control where and when a drug becomes active, ensuring it works exactly where it's needed. For medical treatments to be ...

No safety concerns emerged in part one of the phase 1 trial assessing CS014, a histone deacetylase inhibitor that has potential in treating idiopathic pulmonary fibrosis, in healthy individuals, ...

New study shows dementia patients who are on antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), ...

Adcendo, a biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical need, today announced that the U.S. Food & Drug Administration (FDA) has ...

Innovative platform trial revolutionizes ALS research by testing multiple treatments simultaneously, offering new hope ...

Nick Alves was 19 when a psychiatrist offered him the antidepressant Trintellix to treat his moderate anxiety and depression ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

The first development is the publication of a new book, Doctored, by American investigative journalist Charles Piller, which ...